SAN DIEGO, Jan. 10, 2019 — Medical Marijuana, Inc. (OTC: MJNA), announced today that its subsidiary Kannaway®, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is recognizing its newest pair of Brand Ambassadors to reach the company’s Vice President Director Elite rank.
Franz and Hanka Pollak have achieved the rank of Vice President Director Elite, which requires achieving a minimum of $400,000 in monthly sales. The Pollaks work daily to make sure their teams have all the tools and resources to strategically develop into leaders and host weekly trainings with them.
“Franz and Hanka’s achievement is one to be celebrated,” said Kannaway® CEO Blake Schroeder. “Their commitment to our success and their team members’ successes is admirable and we look forward to supporting them as they reach new milestones and triumphs.”
“Our favorite thing about working with Kannaway is helping people to help themselves,” Franz Pollak said. “For us, the team is the star in our organization and we do everything we can to ensure our common success. Our next goal is to bring a better quality of health and economic security to as many people as possible.”
Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer CMW Media